MET and cancer: As a first step in defining the determinants of MET dependence, we correlated the IC50 values for the MET inhibitor crizotinib with MET gene expression and amplification using publicly available data from the Cancer Cell Line Encyclopedia (CCLE) project (Figure 1) [20].